Don Tracy, Associate Editor

JAMA study evaluates differences in coverage types and potential from 2016-2021.

Findings show that a considerable number of adults remain uneducated on how herpes zoster is triggered.

Blenrep significantly extended the time to disease progression or death against existing care methods as a second-line treatment for relapsed or refractory multiple myeloma.

JAMA study investigates whether consuming energy drinks was associated with adverse pregnancy outcomes and whether caffeine consumption affects fetal-growth restriction.

Law aims to mitigate ongoing global drug shortages.

Trial results expected to accelerate the potential of Dupixent to become the first FDA-approved treatment for chronic obstructive pulmonary disease.

Study aims to find ways industry gets involved in the most influential clinical trials, and how transparent these trials are.

Medication focuses on the acute treatment of migraines.

Study emphasizes role in bridging research and development and commercial/marketing functions.

Heliyon study evaluates online information, labeling accuracy, and quantitative analysis of high peroxide content gels.

JAMA study argues that addressing social determinants of health is crucial to narrowing life expectancy gaps between high- and low-income countries.

The global cost of clinical research and trials is estimated to exceed $85 billion by 2030, which provides an opportunity for artificial intelligence to streamline processes.

Proposed legislation aims to address pharmacy benefit manager tactics to reduce prescription drug prices.

The growing issue of medical debt has caused stakeholders to reevaluate tactics as the cost of pharmaceutical healthcare continues to rise.

Healthy Food Rx provides home-delivered medical prescriptions of healthy food to help address diabetes.

A look into the potential effect of psychedelic drugs on various illnesses, such as mental health conditions.

Company aims to receive approval on a Type II Variation application for Sirturo for patients with pulmonary tuberculosis.

House Committee on Oversight and Accountability request documents on agency’s drug shortage mitigation strategies.

Inflation Reduction Act expected to reduce maximum achievable revenues for many top selling products.

Due to a global demand, treatments such as Adderall and Ritalin have been in short supply for the management of attention-deficit hyperactivity disorder.

The rise in popularity of GLP-1 weight-loss drugs, such as Ozempic, Wegovy, and Mounjaro, has had a wide-reaching impact across the healthcare industry and beyond.

Inpefa to be added on pharmacy benefit manager’s basic and high-performance formularies for commercially insured patients.

SLS009 is a novel CDK9 inhibitor under investigation for the treatment of relapsed/refractory peripheral T-cell lymphomas.

Furmonertinib is in development for the treatment of advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.